Table 2.
Characteristics of thrombotic events, management, and outcome.
| Treatment group (n = 25) | “Wait-and-see” group (n = 7) | Total (n = 32) | |
|---|---|---|---|
| Age at onset (days)* | 11 (6–15) | 15 (10–24) | 13 (7–16) |
| Indication for diagnostic evaluation | |||
| Thrombopenia, n | 14 | 3 | 17 |
| Ongoing Sepsis, n | 4 | 2 | 6 |
| Chance finding, n | 3 | 1 | 4 |
| Catheter obstruction, n | 4 | — | 4 |
| Thalamusbleeding, n | — | 1 | 1 |
| Localization | |||
| Portal vein, n | 2 | — | 2 |
| Ductus venosus, n | 4 | 1 | 5 |
| Heart, n | 10 | 5 | 15 |
| Iliac vein, n | 1 | — | 1 |
| Basilical vein, n | 2 | 1 | 3 |
| Femoral vein, n | 4 | — | 4 |
| Inferior vena cava, n | 2 | — | 2 |
| Hepatic Vein, n | 1 | — | 1 |
| Duration of treatment (days)* | 90 (37–90) | — | — |
| Follow up ultrasound exama | |||
| Complete resolution, n (%) | 17 (68) | 6 (86) | 23 (72) |
| Partial resolution, n | 6 | 1 | 7 |
| Unchanged, n | 1 | — | 1 |
| Unknown, n | 1 | — | 1 |
| Major treatment complications, n | 3 | — | 3 |
*Data presented as median (interquartile range (IQR)).
aFollow up ultrasound performed within 3 months after detection of neonatal thrombosis.